29 results
8-K
EX-99.1
ANNX
Annexon Inc
4 Mar 24
Regulation FD Disclosure
5:25pm
to autoantibodies on nerve components initiating local activation of complement leading to inflammation, recruitment of immune cells, and damage to nerves … Classical Pathway Activity Selectively stops upstream & downstream inflammation driven by classical pathway Immune Cell C4b C4a C4 Recruitment Stops
8-K
EX-99.2
df0q0jzhtz6o9k
31 Jul 23
Annexon Biosciences Strengthens Leadership Team with Appointment of Jamie Dananberg, M.D., as Chief Medical Officer
4:30pm
8-K
EX-99.1
5a5t6f
10 Jan 22
Regulation FD Disclosure
6:40am
10-K
tws jziresvz7b
25 Mar 21
Annual report
7:16am